501432-61-7

Basic information

• Product Name: 6-CHLORO-3-INDOXYL-N-ACETYL-BETA-D-GALACTOSAMINIDE
• Synonyms: 6-CHLORO-3-INDOXYL-N-ACETYL-BETA-D-GALACTOSAMINIDE;6-Chloro-3-indolyl 2-acetamido-2-deoxy-β-D-galactopyranoside;6-Chloro-3-indolyl-N-acetyl-β-galactosaminide;6-Chloro-1H-indol-3-yl 2-(acetylamino)-2-deoxy-beta-D-galactopyranoside;6-Chloro-3-indoxyl-N-acetyl-β-D-galactosaminide
• CAS NO: 501432-61-7
• Molecular Formula: C16H19ClN2O6
• Molecular Weight: 370.78486
• EINECS: 1533716-785-6
• Mol File: 501432-61-7.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 738℃
• Flash Point: 400℃
• Appearance: /
• Density: 1.55
• CAS DataBase Reference: 6-CHLORO-3-INDOXYL-N-ACETYL-BETA-D-GALACTOSAMINIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-CHLORO-3-INDOXYL-N-ACETYL-BETA-D-GALACTOSAMINIDE(501432-61-7)
• EPA Substance Registry System: 6-CHLORO-3-INDOXYL-N-ACETYL-BETA-D-GALACTOSAMINIDE(501432-61-7)

Safety Data

• Hazardous Substances Data: 501432-61-7(Hazardous Substances Data)

Usage

Description

6-CHLORO-3-INDOXYL-N-ACETYL-BETA-D-GALACTOSAMINIDE is a synthetic compound that serves as a chromogenic substrate for the enzyme N-Acetyl-β-D-galactosaminidase. It is characterized by its ability to produce a salmon-colored precipitate upon enzymatic action, which makes it useful in various applications, particularly in the field of biochemistry and medical diagnostics.

Uses

Used in Biochemical Research:
6-CHLORO-3-INDOXYL-N-ACETYL-BETA-D-GALACTOSAMINIDE is used as a research tool for studying the activity and function of N-Acetyl-β-D-galactosaminidase enzyme. The enzyme's action on this substrate results in a visible color change, which can be utilized to monitor enzyme activity, assess enzyme kinetics, and investigate the enzyme's role in various biological processes.
Used in Medical Diagnostics:
In the medical diagnostics industry, 6-CHLORO-3-INDOXYL-N-ACETYL-BETA-D-GALACTOSAMINIDE is used as a diagnostic marker for certain conditions. The enzyme N-Acetyl-β-D-galactosaminidase is involved in the metabolism of glycoconjugates, and its abnormal activity can be indicative of various diseases. By measuring the enzyme's activity using this substrate, medical professionals can gain insights into a patient's health status and make informed decisions regarding diagnosis and treatment.
Used in Drug Development:
6-CHLORO-3-INDOXYL-N-ACETYL-BETA-D-GALACTOSAMINIDE may also be utilized in the development of new drugs targeting N-Acetyl-β-D-galactosaminidase or related enzymes. By understanding how this substrate interacts with the enzyme, researchers can design and synthesize novel compounds that modulate enzyme activity, potentially leading to the development of therapeutic agents for treating diseases associated with abnormal enzyme function.